By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


FORMA Therapeutics, Inc. 

500 Arsenal Street
Suite 100
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-679-1970 Fax: n/a




Company News
Celgene (CELG) Throws Another $195 Million at FORMA To Keep The R&D Pact Going 8/29/2017 8:01:47 AM
FORMA Delivers Two Key Objectives In Collaboration With Celgene (CELG) To Advance Protein Homeostasis Medicines To Benefit Patients 4/10/2017 8:42:57 AM
FORMA Announces Achievement Of First Clinical Development Milestone In Partnership With Boehringer Ingelheim 3/13/2017 6:36:09 AM
FORMA Awarded Grant From The Michael Stern Parkinson's Research Foundation 2/21/2017 8:25:47 AM
FORMA Appoints Jim Winkler, Ph.D., Vice President, Discovery And Translational Biology 10/11/2016 11:45:59 AM
FORMA Achieves Clinical Candidate Licensing Milestone For NASH Compound In Strategic Alliance With Celgene (CELG) 8/31/2016 10:39:09 AM
FORMA Appoints Karoline Shair, Ph.D., J.D., Vice President, Legal And Chief Intellectual Property Counsel 8/29/2016 10:05:17 AM
FORMA And Cancer Research Technology Form A Third Virtual Company To Advance Deubiquitination Assets 1/12/2016 7:51:35 AM
FORMA Achieves An Additional Major Objective In Collaboration With Celgene (CELG) To Advance Innovative Protein Homeostasis Drugs 1/12/2016 7:50:02 AM
FORMA Enrolls First Patient In Phase I Study Of FT-1101 In Advanced Hematological Malignancies 1/12/2016 7:48:55 AM